Development Assistance for Health during Economic Crisis
•Télécharger en tant que PPT, PDF•
1 j'aime•366 vues
This document discusses development assistance for health (DAH) and global health financing trends. It provides an overview of the Institute for Health Metrics and Evaluation's work tracking DAH from 1990-2010, including key findings on channels of assistance and top recipient countries. It also discusses trends in government health spending and the implications of economic uncertainty, including potential declines in DAH funding and increased focus on health program efficiency.
![Outline ,[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommandé
Recommandé
Contenu connexe
Tendances
Tendances (18)
En vedette
Similaire à Development Assistance for Health during Economic Crisis
Similaire à Development Assistance for Health during Economic Crisis (20)
Plus de Institute for Health Metrics and Evaluation - University of Washington
Plus de Institute for Health Metrics and Evaluation - University of Washington (20)
Development Assistance for Health during Economic Crisis
- 1. Financing Global Health 2010: Tracking development assistance for health in economic uncertainty January 31, 2011 Christopher Murray Director, IHME
- 6. Channels of Development Assistance for Health
- 10. DAH by Channel of Assistance, 1990-2010
- 11. DAH by country of origin, 1990-2010
- 12. Public sector DAH by donor country received by channels of assistance, 2008
- 13. Total overseas health expenditures channeled through US NGOs by funding source, 1990-2010
- 14. Fund balances for UN health agencies at end of 2009
- 15. Top 30 country recipients of DAH, 2003-2008, compared with top 30 countries by all-cause burden of disease, 2004
- 16. Total DAH per all-cause DALY, 2003-2008
- 17. DAH for HIV/AIDS by channel of assistance, 1990-2008
- 18. DAH for maternal, newborn, and child health by channel of assistance, 1990-2008
- 20. Domestic Financing of Health by Governments Has Been Increasing
Notes de l'éditeur
- Report Fig. 2
- Report Fig. 4
- Report Fig. 7
- Report Fig. 8
- Report Fig. 10
- Report Fig. 15
- Report Fig. 14
- Report Fig. 17
- Report Fig. 19
- Report Fig. 29
- Average cost of drugs—64% reduction in prices; if all drug companies started to value their drugs in a similar manner, our estimates of in-kind DAH would be greatly reduced.